Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Inv. presentation
|
|
Y-mAbs Therapeutics, Inc. (YMAB)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 06/09/2023 |
4
| Hamill Laura (Director) has filed a Form 4 on Y-mAbs Therapeutics, Inc.|
Txns:
| Granted 2,330 shares
@ $0
Granted 13,950 options to buy
@ $8.13, valued at
$113.4k
|
|
| 06/09/2023 |
4
| Wedell-Wedellsborg Johan (Director) has filed a Form 4 on Y-mAbs Therapeutics, Inc.|
Txns:
| Granted 2,330 shares
@ $0
Granted 13,950 options to buy
@ $8.13, valued at
$113.4k
|
|
| 06/09/2023 |
4
| Ber Gerard (Director) has filed a Form 4 on Y-mAbs Therapeutics, Inc.|
Txns:
| Granted 2,330 shares
@ $0
Granted 13,950 options to buy
@ $8.13, valued at
$113.4k
|
|
| 06/09/2023 |
4
| GILL DAVID N (Director) has filed a Form 4 on Y-mAbs Therapeutics, Inc.|
Txns:
| Granted 2,330 shares
@ $0
Granted 13,950 options to buy
@ $8.13, valued at
$113.4k
|
|
| 06/09/2023 |
4
| HEALY JAMES (Director) has filed a Form 4 on Y-mAbs Therapeutics, Inc.|
Txns:
| Granted 2,330 shares
@ $0
Granted 13,950 options to buy
@ $8.13, valued at
$113.4k
|
|
| 06/09/2023 |
4
| TYAGI ASHU (Director) has filed a Form 4 on Y-mAbs Therapeutics, Inc.|
Txns:
| Granted 2,330 shares
@ $0
Granted 13,950 options to buy
@ $8.13, valued at
$113.4k
|
|
| 05/17/2023 |
4
| Wedell-Wedellsborg Johan (Director) has filed a Form 4 on Y-mAbs Therapeutics, Inc.|
Txns:
| Bought 101,740 shares
@ $9.6462, valued at
$981.4k
|
|
| 05/17/2023 |
4
| WG Biotech ApS (Director) has filed a Form 4 on Y-mAbs Therapeutics, Inc.|
Txns:
| Bought 101,740 shares
@ $9.6462, valued at
$981.4k
|
|
| 01/30/2023 |
4
| Lisby Steen (SVP & CHIEF SCIENTIFIC OFFICER) has filed a Form 4 on Y-mAbs Therapeutics, Inc.|
Txns:
| Granted 32,000 options to buy
@ $4.55, valued at
$145.6k
|
|
| 01/30/2023 |
4
| Lund-Hansen Torben (SVP & CHIEF TECHNICAL OFFICER) has filed a Form 4 on Y-mAbs Therapeutics, Inc.|
Txns:
| Granted 32,000 options to buy
@ $4.55, valued at
$145.6k
|
|
| 01/30/2023 |
4
| Rajah Vignesh (SVP & CHIEF MEDICAL OFFICER) has filed a Form 4 on Y-mAbs Therapeutics, Inc.|
Txns:
| Granted 32,000 options to buy
@ $4.55, valued at
$145.6k
|
|
| 01/30/2023 |
4
| Smith Susan Laura (SVP & CHIEF COMMERCIAL OFFICER) has filed a Form 4 on Y-mAbs Therapeutics, Inc.|
Txns:
| Granted 32,000 options to buy
@ $4.55, valued at
$145.6k
|
|
| 01/30/2023 |
4
| Wilms Joris (SVP & COO) has filed a Form 4 on Y-mAbs Therapeutics, Inc.|
Txns:
| Granted 32,000 options to buy
@ $4.55, valued at
$145.6k
|
|
| 01/19/2023 |
4
| Rajah Vignesh (SVP & CHIEF MEDICAL OFFICER) has filed a Form 4 on Y-mAbs Therapeutics, Inc.|
Txns:
| Granted 17,800 shares
@ $0
Granted 35,700 options to buy
@ $4.7, valued at
$167.8k
|
|
| 01/19/2023 |
4
| Lund-Hansen Torben (SVP & CHIEF TECHNICAL OFFICER) has filed a Form 4 on Y-mAbs Therapeutics, Inc.|
Txns:
| Granted 17,800 shares
@ $0
Granted 35,700 options to buy
@ $4.7, valued at
$167.8k
|
|
| 01/19/2023 |
4
| Gad Thomas (See remarks) has filed a Form 4 on Y-mAbs Therapeutics, Inc.|
Txns:
| Granted 40,500 shares
@ $0
Granted 243,200 options to buy
@ $4.7, valued at
$1.1M
|
|
| 01/19/2023 |
4
| Smith Susan Laura (SVP & CHIEF COMMERCIAL OFFICER) has filed a Form 4 on Y-mAbs Therapeutics, Inc.|
Txns:
| Granted 17,800 shares
@ $0
Granted 35,700 options to buy
@ $4.7, valued at
$167.8k
|
|
| 01/19/2023 |
4
| Lisby Steen (SVP & CHIEF SCIENTIFIC OFFICER) has filed a Form 4 on Y-mAbs Therapeutics, Inc.|
Txns:
| Granted 17,800 shares
@ $0
Granted 35,700 options to buy
@ $4.7, valued at
$167.8k
|
|
| 01/19/2023 |
4
| Wilms Joris (SVP & COO) has filed a Form 4 on Y-mAbs Therapeutics, Inc.|
Txns:
| Granted 17,800 shares
@ $0
Granted 35,700 options to buy
@ $4.7, valued at
$167.8k
|
|
| 01/19/2023 |
4
| Kruse Bo (EVP, CFO, Secry & Treas.) has filed a Form 4 on Y-mAbs Therapeutics, Inc.|
Txns:
| Granted 11,700 shares
@ $0
Granted 70,100 options to buy
@ $4.7, valued at
$329.5k
|
|
| 11/16/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/19/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/19/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/19/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/19/2022 |
4
| Ber Gerard (Director) has filed a Form 4 on Y-mAbs Therapeutics, Inc.|
Txns:
| Granted 16,000 options to buy
@ $16.64, valued at
$266.2k
|
|
| 07/19/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/19/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/19/2022 |
4
| Gad Thomas (See remarks) has filed a Form 4 on Y-mAbs Therapeutics, Inc.|
Txns:
| Granted 60,000 options to buy
@ $9.52, valued at
$571.2k
|
|
| 04/28/2022 |
4
| Rajah Vignesh (SVP & CMO) has filed a Form 4 on Y-mAbs Therapeutics, Inc.|
Txns:
| Granted 20,000 options to buy
@ $9.51, valued at
$190.2k
|
|
| 04/28/2022 |
4
| Lund-Hansen Torben (SVP & CTO) has filed a Form 4 on Y-mAbs Therapeutics, Inc.|
Txns:
| Granted 20,000 options to buy
@ $9.51, valued at
$190.2k
|
|
| 04/28/2022 |
4
| Smith Susan Laura (SVP & CCO) has filed a Form 4 on Y-mAbs Therapeutics, Inc.|
Txns:
| Granted 20,000 options to buy
@ $9.51, valued at
$190.2k
|
|
| 04/28/2022 |
4
| Lisby Steen (SVP & CSO) has filed a Form 4 on Y-mAbs Therapeutics, Inc.|
Txns:
| Granted 20,000 options to buy
@ $9.51, valued at
$190.2k
|
|
| 04/28/2022 |
4
| Wilms Joris (SVP & COO) has filed a Form 4 on Y-mAbs Therapeutics, Inc.|
Txns:
| Granted 20,000 options to buy
@ $9.51, valued at
$190.2k
|
|
| 04/28/2022 |
4
| Kruse Bo (EVP, CFO, Secretary & Treas.) has filed a Form 4 on Y-mAbs Therapeutics, Inc.|
Txns:
| Granted 75,000 options to buy
@ $9.51, valued at
$713.3k
|
|
|
|
|